Compile Data Set for Download or QSAR
Report error Found 334 Enz. Inhib. hit(s) with all data for entry = 9655
TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479289BDBM479289(US10894789, Compound 233)
Affinity DataIC50: 1nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479267BDBM479267(US10894789, Compound 66)
Affinity DataIC50: 1nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479282BDBM479282(US10894789, Compound 221)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479203BDBM479203(US10894789, Compound 78)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479241BDBM479241(US10894789, Compound 185)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479169BDBM479169(US10894789, Compound 125)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479230BDBM479230(US10894789, Compound 21)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479176BDBM479176(US10894789, Compound 123)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479229BDBM479229(US10894789, Compound 120)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479268BDBM479268(US10894789, Compound 65)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479227BDBM479227(US10894789, Compound 211)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479243BDBM479243(US10894789, Compound 169)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479201BDBM479201(US10894789, Compound 150)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479239BDBM479239(US10894789, Compound 30)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479190BDBM479190(US10894789, Compound 23)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479308BDBM479308(US10894789, Compound 264)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479174BDBM479174(US10894789, Compound 63)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479157BDBM479157(US10894789, Compound 197)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479202BDBM479202(US10894789, Compound 77)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479185BDBM479185(US10894789, Compound 26)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479169BDBM479169(US10894789, Compound 125)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479168BDBM479168(US10894789, Compound 124)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479151BDBM479151(US10894789, Compound 33)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479198BDBM479198(US10894789, Compound 142)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479150BDBM479150(US10894789, Compound 129 | Compound 185: ((2S,3R)-...)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479165BDBM479165(US10894789, Compound 29)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479273BDBM479273(US10894789, Compound 217)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479272BDBM479272(US10894789, Compound 216)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479178BDBM479178(US10894789, Compound 64)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479238BDBM479238(US10894789, Compound 31)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479144BDBM479144(US10894789, Compound 200)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479191BDBM479191(US10894789, Compound 25)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479175BDBM479175(US10894789, Compound 134)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479159BDBM479159(US10894789, Compound 174)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479252BDBM479252(US10894789, Compound 51)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479158BDBM479158(US10894789, Compound 175)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479266BDBM479266(US10894789, Compound 67)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479172BDBM479172(US10894789, Compound 137)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479297BDBM479297(US10894789, Compound 242)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479179BDBM479179(US10894789, Compound 122)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479271BDBM479271(US10894789, Compound 215)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479192BDBM479192(US10894789, Compound 121)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479161BDBM479161(US10894789, Compound 147)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479237BDBM479237(US10894789, Compound 70)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479197BDBM479197(US10894789, Compound 167)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479186BDBM479186(US10894789, Compound 32)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479156BDBM479156(US10894789, Compound 177)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479171BDBM479171(US10894789, Compound 138)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479265BDBM479265(US10894789, Compound 49)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 479155BDBM479155(US10894789, Compound 186)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 334 total ) | Next | Last >>
Jump to: